Initial Public Offering(IPO)
Belite Bio announces registered direct offering of $15 million
Belite Bio, Inc, a clinical-stage biopharmaceutical drug development compan...
Silo Pharma announces closing of $2.1 Million direct offering
Silo Pharma, Inc., a developmental stage biopharmaceutical company focused ...
TransCode Therapeutics, Inc. announces pricing of public offering
TransCode Therapeutics, Inc., a clinical-stage RNA oncology company committ...
Aptevo Therapeutics announces closing of $2.75 million offering
Aptevo Therapeutics Inc., a clinical-stage biotechnology company focused on...
IPO Fever Grips Biotech Industry
The COVID-19-induced upsurge in biotech and pharma IPOs in 2020-21 dipped s...
Organovo Holdings, Inc. announces pricing of $5.25 million public offering
Organovo Holdings, Inc., a clinical stage biotechnology company focused on ...
EzeRx is contemplating IPO launch as part of the future endeavours
What major plans are in store for the company in FY 24-25? In FY 24-25, Ez...
Mustang Bio announces pricing of $4 million public offering
Mustang Bio, Inc., a clinical-stage biopharmaceutical company focused on tr...
Gritstone Bio announces proposed public offering
Gritstone bio, Inc., a clinical-stage biotechnology company working to deve...
Longeveron Announces Closing of $4 Million Direct Offering
Longeveron Inc., a clinical stage biotechnology company developing cellular...
Cerevel Therapeutics Announces Pricing of $450 Million Public Offering
Cerevel Therapeutics Holdings, Inc., a company dedicated to unraveling the ...
ALX Oncology Announces Proposed Public Offering
ALX Oncology Holdings Inc., an immuno-oncology company developing therapies...
TransCode Therapeutics Announces Pricing of $8 Million Public Offering
TransCode Therapeutics, Inc. an RNA oncology company committed to more effe...
CymaBay Announces Pricing of Upsized $225 Million Public Offering
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company focu...
Yield10 Bioscience Announces Closing of $3.7 Million Public Offering
Yield10 Bioscience, Inc., an agricultural bioscience company, announc...
180 Life Sciences Corp. Announces Pricing of $3 Million Public Offering
180 Life Sciences Corp., a clinical-stage biotechnology company, anno...
Tonix Pharmaceuticals Announces Closing of $7 Million Public Offering
Tonix Pharmaceuticals Holding Corp, a biopharmaceutical company, anno...
